SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
HuMAB companies
An SI Board Since May 2000
Posts SubjectMarks Bans
1022 55 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
997I had a quick look and couldn't find anything. (FWIW)nigel bates-10/30/2013
996Here is the clintrials listing on this trial: clinicaltrials.gov I could not fBiotech Jim-10/30/2013
995GHENT, Belgium, 29 October 2013 - Ablynx [Euronext Brussels: ABLX] today announcnigel bates-10/30/2013
994GHENT, Belgium and NORTH CHICAGO, Illinois, 23 September 2013 - Ablynx [Euronextnigel bates19/23/2013
993LONDON, Sept 19 (Reuters) - Britain's GlaxoSmithkline said it had signed a nnigel bates-9/19/2013
992GHENT, Belgium, 4 July 2013 - Ablynx (Euronext Brussels: ABLX) today announced tnigel bates-7/8/2013
991GHENT, Belgium, 28 February 2013 - Ablynx [Euronext Brussels: ABLX], the biopharnigel bates-3/2/2013
990Those results do look exciting. Congratulations Nigel. AshleyA.J. Mullen-2/13/2013
989ABLYNX’S ANTI-IL-6R NANOBODY, ALX-0061, SHOWS EXCELLENT 24 WEEK SAFETY AND EFFInigel bates-2/13/2013
988Lund, Sweden – January 24, 2013 – BioInvent International (OMXS:BINV) announced nigel bates-1/24/2013
987MorphoSys's MOR103 Antibody Demonstrates Excellent Safety and Efficacy in RhGermanecki-9/21/2012
986Humira to take #1 spot in Rx universe. Biologic against pills, it is time to chMiljenko Zuanic-4/11/2012
985 MorphoSys Unveils Next-Generation Antibody Technology Ylanthia® DecembeGermanecki-12/8/2011
984>>The next step will be to investigate whether removal of brain amyloid trnigel bates-10/12/2011
983Study Shows That Roche's Investigational Drug for Alzheimer's Disease ReGermanecki-10/10/2011
982Don't disagree - I was just relieved it wasn't a bust. Yet.nigel bates-5/19/2011
981Doesn't sound especially bullish, IMO: siliconinvestor.com Regards, DewDewDiligence_on_SI-5/18/2011
980GHENT, Belgium, 17 May 2011 – Ablynx [Euronext Brussels: ABLX] today announced tnigel bates-5/18/2011
979GHENT, Belgium, 28 March 2011 - Ablynx [Euronext Brussels: ABLX] announced todaynigel bates-4/4/2011
978GHENT, Belgium, 9 January 2011 - Ablynx [Euronext Brussels: ABLX] announces an unigel bates-1/10/2011
977GHENT, Belgium, 8 December 2010 - Ablynx [Euronext Brussels: ABLX] today announcnigel bates-12/20/2010
976GHENT, Belgium, 11 October 2010 – Ablynx [Euronext Brussels: ABLX] and Merck Sernigel bates-10/16/2010
975Been busy with other stuff, so posting this rather late, but it looked interestinigel bates-10/2/2010
974MorphoSys Initiates Program Against Drug-Resistant MRSA Infections September 02,Germanecki-9/2/2010
973MorphoSys to Present at Three Investor Conferences in September September 01, 20Germanecki-9/2/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News